Access cutting-edge non-hodgkin's lymphoma treatment through this clinical trial at a research site in Harvey. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Harvey location
Access non-hodgkin's lymphoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-hodgkin's lymphoma treatment provided free
Check if you qualify for this non-hodgkin's lymphoma clinical trial in Harvey, IL
No-Cost Study Care
Local to Harvey
Convenient for IL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a Phase I/II, multicenter, open-label, dose-escalation study designed to evaluate the efficacy, safety, tolerability and pharmacokinetics (PK) of a novel T-Cell bispecific (TCB), glofitamab, administered by intravenous (IV) infusion as a single agent and in combination with obinutuzumab, following pre-treatment with a one-time, fixed dose of obinutuzumab. This entry-into-human (EIH) study is divided in 3 parts: dose escalation (Parts I and II) and dose expansion (Part III). Single-partic
Sponsor: Hoffmann-La Roche
Yes, this clinical trial (NCT03075696) has an active research site in Harvey, IL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for non-hodgkin's lymphoma treatment options in Harvey, IL, this clinical trial (NCT03075696) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Harvey research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-hodgkin's lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all non-hodgkin's lymphoma clinical trials near you to find additional studies recruiting in your area.
See all lymphoma clinical trials recruiting in Harvey — not just this study.
Browse Lymphoma Trials in Harvey →